Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
May 7, 2008
Emergent BioSolutions Reports Financial Results for First Quarter 2008
...
Read More
May 5, 2008
Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate and Technology
...
Read More
April 10, 2008
Emergent BioSolutions to Release First Quarter 2008 Financial Results and Conduct a Conference Call On May 7, 2008
...
Read More
April 8, 2008
Emergent BioSolutions to Hold Annual Meeting of Stockholders Wednesday, May 21, 2008 at 10:00 am Eastern
...
Read More
March 10, 2008
Emergent BioSolutions to Present at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
...
Read More
March 7, 2008
Emergent BioSolutions Reports Financial Results for 2007
...
Read More
March 7, 2008
Emergent BioSolutions Acquires Monoclonal Anthrax Product Candidate
...
Read More
March 3, 2008
Emergent BioSolutions Appoints Dr. W. James Jackson as Chief Scientific Officer
...
Read More
February 25, 2008
Emergent BioSolutions to Release Full Year 2007 Financial Results and Conduct a Conference Call on March 7, 2008
...
Read More
February 7, 2008
Emergent BioSolutions to Present at BIO CEO & Investor Conference on February 11, 2008
...
Read More
January 24, 2008
Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia
...
Read More
January 9, 2008
Safety Monitoring Committee Recommends That Emergent BioSolutions Continue Its Hepatitis B Immunotherapy Phase II Trial
...
Read More
1
2
…
52
53
54
…
58
59
